William F. Chaplin

11.6k total citations · 1 hit paper
134 papers, 8.2k citations indexed

About

William F. Chaplin is a scholar working on Clinical Psychology, Cardiology and Cardiovascular Medicine and Social Psychology. According to data from OpenAlex, William F. Chaplin has authored 134 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Clinical Psychology, 35 papers in Cardiology and Cardiovascular Medicine and 29 papers in Social Psychology. Recurrent topics in William F. Chaplin's work include Blood Pressure and Hypertension Studies (21 papers), Cardiac Health and Mental Health (18 papers) and Autism Spectrum Disorder Research (14 papers). William F. Chaplin is often cited by papers focused on Blood Pressure and Hypertension Studies (21 papers), Cardiac Health and Mental Health (18 papers) and Autism Spectrum Disorder Research (14 papers). William F. Chaplin collaborates with scholars based in United States, Canada and United Kingdom. William F. Chaplin's co-authors include Eric Hollander, Stacey Wasserman, Latha Soorya, Evdokia Anagnostou, Lewis R. Goldberg, Peter M. Lewinsohn, Antoinette Schoenthaler, Walter Mischel, Russell Barton and Oliver P. John and has published in prestigious journals such as Circulation, Journal of Personality and Social Psychology and Journal of the American College of Cardiology.

In The Last Decade

William F. Chaplin

132 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxytocin Increases Retention of Social Cognition in Autism

2006 539 citations Eric Hollander, William F. Chaplin et al. profile →

Peers

Countries citing papers authored by William F. Chaplin

Since Specialization

Citations

This map shows the geographic impact of William F. Chaplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William F. Chaplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William F. Chaplin more than expected).

Fields of papers citing papers by William F. Chaplin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William F. Chaplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William F. Chaplin. The network helps show where William F. Chaplin may publish in the future.

Co-authorship network of co-authors of William F. Chaplin

This figure shows the co-authorship network connecting the top 25 collaborators of William F. Chaplin. A scholar is included among the top collaborators of William F. Chaplin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William F. Chaplin. William F. Chaplin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and Evaluation of the Firefighter Exposure to Carcinogens Scale 2025 ·Journal of Occupational and Environmental Medicine ·Patrick J. McGrath, Maryam Akbari‐Fakhrabadi, William F. Chaplin, (unknown), (unknown), (unknown), Jim Petrik, Ian Irwin, Alberto J. Caban‐Martinez, (unknown), Ting Xiong, (unknown), JianLi Wang, Igor Yakovenko	0
2	Translational Research of the Acute Effects of Negative Emotions on Vascular Endothelial Health: Findings From a Randomized Controlled Study 2024 ·Journal of the American Heart Association ·Daichi Shimbo, (unknown), (unknown), Ipek Ensari, Keith M. Diaz, (unknown), Andrea T. Duran, Shuqing Zhao, Jerry Suls, Matthew M. Burg, William F. Chaplin	7
3	What Cognitions Best Predict Disturbed Anger in Adults? A Revision of the Anger Cognitions Scale 2023 ·Cognitive Therapy and Research ·Raymond DiGiuseppe, (unknown), (unknown), (unknown), (unknown), William F. Chaplin	2
4	Uptake of Task-Strengthening Strategy for Hypertension (TASSH) control within Community-Based Health Planning Services in Ghana: study protocol for a cluster randomized controlled trial 2020 ·Trials ·Kwaku Poku Asante, Juliet Iwelunmor, (unknown), Joyce Gyamfi, Solomon Nyame, (unknown), Angela Aifah, (unknown), (unknown), William F. Chaplin, Gbenga Ogedegbe, Jacob Plange‐Rhule	9
5	A Systems-Level Approach to Improving Medication Adherence in Hypertensive Latinos: a Randomized Control Trial 2019 ·Journal of General Internal Medicine ·Antoinette Schoenthaler, (unknown), (unknown), (unknown), William F. Chaplin, Jazmin N. Mogavero, Milagros C. Rosal	13
6	The role of interpersonal sensitivity, social support, and quality of life in rural older adults 2016 ·Geriatric Nursing ·(unknown), Michael LaRocca, William F. Chaplin, Forrest Scogin	66
7	An Electronic Adherence Measurement Intervention to Reduce Clinical Inertia in the Treatment of Uncontrolled Hypertension: The MATCH Cluster Randomized Clinical Trial 2016 ·Journal of General Internal Medicine ·Ian M. Kronish, Nathalie Moise, Thomas McGinn, (unknown), William F. Chaplin, (unknown), Karina W. Davidson	18
8	Perceived Discrimination and Medication Adherence in Black Hypertensive Patients 2014 ·Psychosomatic Medicine ·Jessica M. Forsyth, Antoinette Schoenthaler, William F. Chaplin, Gbenga Ogedegbe, Joseph Ravenell	50
9	Teacher burnout: a comparison of two cultures using confirmatory factor and item response models 2013 ·PubMed ·(unknown), William F. Chaplin, Melanie M. Wall	24
10	Psychosocial Vulnerabilities to Depression after Acute Coronary Syndrome: The Pivotal Role of Rumination in Predicting and Maintaining Depression 2012 ·Frontiers in Psychology ·Ellen‐ge Denton, Nina Rieckmann, Karina W. Davidson, William F. Chaplin	14
11	The Perceived Ethnic Discrimination Questionnaire—Community Version: Validation in a multiethnic Asian sample. 2011 ·Cultural Diversity & Ethnic Minority Psychology ·(unknown), (unknown), (unknown), Robert Crupi, Daniel Chen, Alan Roth, William F. Chaplin, Elizabeth Brondolo	35
12	Observed Hostility and the Risk of Incident Ischemic Heart Disease 2011 ·Journal of the American College of Cardiology ·Jonathan Newman, Karina W. Davidson, Jonathan A. Shaffer, Joseph E. Schwartz, William F. Chaplin, Susan Kirkland, Daichi Shimbo	20
13	Collaborative Care for Depressed Patients With Chronic Medical Conditions: A Randomized Trial in Puerto Rico 2010 ·Psychiatric Services ·Mildred Vera, (unknown), (unknown), (unknown), (unknown), (unknown), Mae Lynn Reyes‐Rodríguez, William F. Chaplin	46
14	Abstract 14790: Polypharmacy is a Predictor of Medication Non-adherence after Acute Coronary Syndrome: An Electronic Medication Monitoring Study 2010 ·Circulation ·Siqin Ye, Nina Rieckmann, Ian M. Kronish, Manjunath Harlapur, Matthew M. Burg, Joseph E. Schwartz, William F. Chaplin, Karina W. Davidson	1
15	Double-Blind, Placebo-Controlled Trial of Topiramate Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder 2010 ·The Journal of Clinical Psychiatry ·Heather A. Berlin, (unknown), Michael A. Jenike, Nathan A. Shapira, William F. Chaplin, Stefano Pallanti, Eric Hollander	87
16	Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans 2008 ·Journal of Behavioral Medicine ·Senaida Fernandez, William F. Chaplin, Antoinette Schoenthaler, Gbenga Ogedegbe	101
17	The medication Adherence and Blood Pressure Control (ABC) trial: A multi-site randomized controlled trial in a hypertensive, multi-cultural, economically disadvantaged population 2007 ·Contemporary Clinical Trials ·William Gerin, Jonathan N. Tobin, Joseph E. Schwartz, William F. Chaplin, Nina Rieckmann, Karina W. Davidson, Tanya Goyal, (unknown), Andrea Cassells, (unknown), (unknown), (unknown), Gbenga Ogedegbe	23
18	ADouble-Blind Placebo-Controlled Pilot Study of Olanzapine in Childhood/Adolescent Pervasive Developmental Disorder 2006 ·Journal of Child and Adolescent Psychopharmacology ·Eric Hollander, Stacey Wasserman, Erika N. Swanson, William F. Chaplin, (unknown), (unknown), Sherie Novotny	125
19	Superiority of ambulatory to physician blood pressure is not an artifact of differential measurement reliability 2006 ·Blood Pressure Monitoring ·William Gerin, Joseph E. Schwartz, Richard B. Devereux, Tanya Goyal, Daichi Shimbo, Gbenga Ogedegbe, Nina Rieckmann, Dennis Abraham, William F. Chaplin, Matthew M. Burg, (unknown), Thomas G. Pickering	13
20	Positive Aspects of Alzheimer's Caregiving: The Role of Race 2004 ·The Journals of Gerontology Series B ·Lucinda Lee Roff, Louis D. Burgio, Laura N. Gitlin, Linda O. Nichols, William F. Chaplin, (unknown)	146

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact